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ABSTRACT: Parkinson’s disease (PD) is characterized by the presence of cytoplasmic inclusions composed
of R-synuclein (R-syn) in dopaminergic neurons. This suggests a pivotal role of dopamine (DA) on PD
development. Here, we show that DA modulates differently the stability of protofibrils (PF) and fibrils
(F) composed of wild type or variants of R-syn (A30P and A53T) as probed by high hydrostatic pressure
(HHP). While in the absence of DA, all R-syn PF exhibited identical stability, in its presence, the variant-
composed PF acquired a greater stability (DAPFwt < DAPFA30P ) DAPFA53T), implying that they would
last longer, which could shed light onto why these mutations are so aggressive. When R-syn was incubated
for long times (18 days) in the presence of DA, we observed the formation of F by electronic microscopy,
suggesting that the PF trapped in the presence of DA in short times can evolve into F. The stability of F
was also altered by DA. DAFwt was more labile than Fwt, indicating that the former would be more
susceptible to breakage. PFA30P and DAPFA30P, when added to mesencephalic and cortical neurons in
culture, decreased the number and length of neurites and increased the number of apoptotic cells.
Surprisingly, these toxic effects of PFA30P and DAPFA30P were practically abolished with HHP treatment,
which was able to break the PF into smaller aggregates, as seen by atomic force microscopy. These
results suggest that strategies aimed at breaking and/or clearing these aggregates is promising in alleviating
the symptoms of PD.
Parkinson’s disease (PD)1 is the second most common
neurodegenerative brain disorder, after Alzheimer’s disease,
affecting 1% of the population over 65 years of age (1).
The symptoms of PD include difficulty in initiating move-
ments, resting tremor, muscular rigidity, impaired postural
reflexes, and bradykinesia, resulting from the loss of dopa-
minergic neurons and depletion of dopamine (DA) in the
regions of the brain involved in motor functions [the
substantia nigra (SN)] (2). The remaining neurons of the
SN are characterized by the presence of an intracellular
inclusion, known as Lewy bodies (LB), composed primarily
of fibrillar R-synuclein (R-syn) (3-6).
R-syn is a 140 amino acid, “natively unfolded” protein
with unknown function, although recent studies suggest that
it may play a role in regulating the reserve pool of synaptic
vesicles in the brain (7, 8). Genetic findings support a strong
link between R-syn and PD. Three mutations, A30P, E46K,
and A53T, are linked to rare, early onset forms of PD (9-
11). Duplication and triplication in the gene encoding R-syn
have also been described in familial PD (12), suggesting that
increased expression is sufficient to cause PD. Although
fewer than 10% of Parkinson’s cases are linked to the
presence of these mutations in the R-syn gene (13), detailed
characterization of these variants may provide critical insight
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into the mechanism by which these mutations alter the
properties and/or function of R-syn and thus may help to
unravel the mechanism(s) of R-syn-induced neurodegenera-
tion in PD.
Neuropathologic findings based on postmortem examina-
tion of normal and diseased human brains as well as studies
of transgenic mouse and flies overexpressing R-syn (wild
type and PD variants) support the hypothesis that prefibrillar
R-syn aggregates (PF) might be the pathogenic species in
PD and suggest that fibril formation by R-syn may be
protective in PD (14, 15). First, a transgenic mouse model
expressing human or mouse wild-type R-syn shows PD-like
symptoms, including degeneration of dopaminergic nerve
terminals and formation of cytoplasmic, nonfibrillar R-syn
inclusions (16). Second, all mutations (A30P, A53T, and
E46K) associated with familial PD accelerate R-syn protofibril
(A53T and A30P) and/or fibril (A53T and E46K) formation
in vitro when compared to the wild-type protein (11, 17-
19). Furthermore, protofibrillar forms of R-syn but not
monomers or F were shown to permeabilize synthetic
vesicles in vitro; the permeabilization activity of R-syn was
enhanced in the case of the disease variants A30P and A53T
(20).
DA has been shown to interact with R-syn to form R-syn-
DA adduct(s) which are thought to inhibit the conversion of
R-syn PF into F. These findings support the hypothesis that
protofibrillar R-syn is the pathogenic species and offer a
possible explanation for the selective degeneration of dopa-
minergic neurons in PD (15, 21, 22). The inhibitory activity
of DA depends upon its oxidative breakdown and seems to
be selective for the protofibril-fibril conversion (15, 21).
In addition, DA, L-dopa, and other catecholamines were able
to prevent and/or disaggregate amyloid F of R-syn produced
in vitro. These findings suggest that the R-syn interaction
with DA promotes the accumulation of potentially toxic
protofibrillar intermediates both during amyloid formation
and dissociation and support the hypothesis that R-syn
fibrillization reflects a detoxification strategy by which
dopaminergic neurons sequester toxic intermediates.
Recently, we demonstrated that amyloid F composed of
transthyretin or R-syn were destabilized by high hydrostatic
pressure (HHP) (23). In the case of R-syn, the F produced
from the disease-associated variants were more sensitive than
wild-type F to HHP. This result suggests that, although all
amyloid F share a common architecture (the cross â sheet)
(24, 25), regardless of the primary sequence or structure of
the precursor amyloidogenic protein, the side-chain contacts
play a significant role in the fine adjustment of fibril
architecture, packing, and stability (23).
The aim of the present study was to evaluate the effects
of DA on the stability of the in vitro grown PF and F
composed of the wild type or variant (A53T and A30P)
R-syn. Any change in PF and F stabilities modulated by DA
could represent an enhancement or a decrease in their
longevity in dopaminergic neurons and consequently in their
toxicity. Although other neuronal groups are also affected
in PD, mainly in the patients bearing mutations (8), any
change in the stability of these aggregates promoted by DA
could shed light onto why the dopaminergic neurons are so
vulnerable in PD. It has been shown that DA inhibits
protofibril-fibril conversion (15, 21, 26); however, in longer
incubation times, as used here (18 days), we observe the
appearance of F in the presence of DA. Thus, we grew PF
and F from wild-type and variant R-syn in the absence or
presence of DA (here called DAPF and DAF) and subjected
all of them to HHP. Our results show that, in the absence of
DA, the conversion of PF into F is accompanied by a gain
in stability, especially in the case of the wild type; this would
render the nontoxic fibril a very stable species, freeing the
nondopaminergic regions of the brain from the toxic effects
of the PF. In the presence of DA (mimicking the conditions
in dopaminergic neurons), the DAPF composed of the
variants were more resistant to pressure denaturation than
DAPFwt, suggesting that the former would last longer in
dopaminergic regions of the brain, thus explaining the faster
progression of the disease in patients with R-syn mutations
with an increased susceptibility of the dopaminergic neurons
in PD. We also investigated the toxicity of PFA30P and
DAPFA30P added to cortical and mesencephalic embryonic
neurons in culture. Both aggregates of A30P were highly
toxic to these neurons. Interestingly, the HHP treatment
significantly reduced the toxicity of PFA30P and DAPFA30P,
an observation that reinforces their toxic role in PD.
EXPERIMENTAL PROCEDURES
Production of F and PF of R-syn. Recombinant R-syn was
expressed and purified as described (27). Solutions with 50
íM wild type, A30P, or A53T were incubated in buffer A
[5 mM tris(hydroxymethyl-aminomethane) (Tris)-HCl and
100 mM NaCl at pH 7.0] at 37 °C at atmospheric pressure
under gentle stirring. Fibril formation was monitored by
thioflavin T (Thio-T) binding until the steady state was
reached. R-syn PF were generated by incubating the protein
solutions as described for 2 days only. Then, the solutions
were centrifuged at 5000g for 5 min, and the supernatant
was applied to the Superdex 200 (HR 10/30) column to
remove the remaining monomers. The peak corresponding
to the oligomeric form was collected and immediately
subjected to HHP treatment. DAPF and DAF were produced
as described (21, 22). Briefly, 50 íM of the wild type or
variants of R-syn were incubated with equimolar concentra-
tions of DA and aggregated for 2-3 days at 37 °C to produce
DAPF or for 18 days to produce DAF. The influence of
oxygen on DAF formation was investigated by incubating
the samples under the same conditions but in an atmosphere
enriched in nitrogen gas.
Thio-T Binding. Aliquots of 10 íL of the aggregating
solutions were withdrawn and mixed with 50 íL of 500 íM
Thio-T solution (Sigma Co.) prepared in 50 mM glycine at
pH 8.5, in a total volume of 1 mL. Thio-T binding was
evaluated by monitoring the changes in the emission spectra
of Thio-T from 460 to 570 nm upon exciting the samples at
446 nm. The presence of DA in the aggregating solutions
did not interfere with the fluorescence emission of Thio-T
or 1,1′-bis(4-aniline-5-naphthalene sulfonate) (bis-ANS).
Bis-ANS Binding. Aliquots of 5 íL of the aggregating
solutions were mixed with 5 íL of an aqueous solution of
1.5 mM bis-ANS (Molecular Probes) in a total volume of 1
mL, and the binding of bis-ANS to the aggregates was
determined by measuring the spectral area of the emission
spectrum (400-600 nm) upon exciting the samples at 360
nm.
Dissociation of R-syn Aggregates by HHP. The aggregated
protein samples were diluted to a final concentration of 16
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íM in buffer A and then subjected to HHP treatment. The
high-pressure cell equipped with optical windows has already
been described (28) and was purchased from ISS (Cham-
paign, IL). To evaluate the average size distribution of R-syn
aggregates in solution, light scattering (LS) was measured
by exciting the samples at 320 nm and collecting the light
at 90° from 315 to 325 nm in an ISS K2 spectrofluorometer.
To evaluate the time dependence of the pressure-induced
dissociation of R-syn aggregates, kinetic experiments were
performed by keeping the pressure fixed at 2170 bar and
recording the LS at intervals of 5 min until the steady state
was reached (60 min). In the experiments where the pressure
dependence was measured, the pressure was increased from
1 to 3000 bar in steps of 270 bar, waiting 15-20 min before
each measurement. All measurements were performed at 37
°C or as stated in the figure captions.
Transmission Electron Microscopy (TEM). The ultrastruc-
ture of the different aggregates of R-syn was characterized
using negative-staining TEM. The R-syn F and R-syn-DAF
solutions (50 íM) were diluted 12-fold, and 10 íL of this
solution was deposited on a Formvar-coated copper grid. The
samples were stained with 10 íL of uranyl acetate (2%
aqueous solution) for 1 min, dried, and then examined in a
JEOL 1200EX, operated at 80 kV.
Atomic Force Microscopy (AFM). A total of 10 íL of each
sample was adsorbed onto the mica surface, dried at room
temperature for 1-2 h, and then rinsed twice gently with
50 íL of MilliQ water before drying with nitrogen. AFM
images were obtained at room temperature using a MFP-3D
(Asylum Research, Santa Barbara, CA) in intermittent contact
mode at 0.5 Hz and Si cantilevers (AC240TS, Olympus; with
a spring constant of 1.32 N/m and nominal tip radius lower
than 10 nm). Spring constants were measured by the thermal
noise method. Image analysis was performed with the Igor
Pro 5.0 image processing package (WaveMetrics, Inc.,
Portland, OR).
Neuron Primary Cultures. Neurons from the midbrain and
cerebral cortex of 14-day-old Swiss mice (E14) were
prepared as previously described (29) and modified by
Garcia-Abreu and co-workers (30). All animals were kept
under standard laboratory conditions according to National
Institutes of Health guidelines. Mice anaesthetized by hy-
pothermia were decapitated; the brain structures were
removed; and the meninges were carefully stripped off.
Dissociated cells were plated on coverslips previously coated
with polyornithine (1.5 íg/mL, molecular weight ) 41 000;
Sigma Chem. Co., St Louis, MO), in serum-free neurobasal
medium supplemented with B27 (Invitrogen, Carlsbad, CA).
For immunocytochemistry assays, cells were plated on
polyornithine-treated glass coverslips. The cultures were
incubated at 37 °C in a humidified 5% CO2 and 95% air
chamber for 24 h.
Immunocytochemistry. Immunocytochemistry was per-
formed as previously described (31). Briefly, cultured cells
were fixed with 4% paraformaldehyde for 20 min and
permeabilized with 0.2% Triton X-100 for 5 min at room
temperature. After permeabilization, cells were blocked with
10% normal goat serum (Vector Laboratories, Inc., Burlin-
game, CA) in phosphate-buffered saline (PBS) (blocking
solution) for 1 h and incubated overnight at room temperature
with the specified primary antibodies diluted in blocking
solution. For peroxidase staining, prior to the primary
antibody incubation, endogenous peroxidase activity was
abolished with 3% H2O2 for 10 min, followed by extensive
washing with PBS. The primary antibody was mouse
antihuman â-tubulin III antibody (Promega Corporation;
1:500). After primary antibody incubation, cells were
extensively washed with PBS/10% normal goat serum and
incubated with secondary antibodies for 1 h at room
temperature. Secondary antibodies were conjugated with
horseradish peroxidase (goat antimouse; Sigma Chemical
Co.; 1:100) or with fluorescein isothyocyanate (sheep anti-
mouse; Sigma Chemical Co.; 1:400). Peroxidase activity was
revealed with 3,3′-diaminobenzidine (DAB peroxidase sub-
strate kit; Vector Laboratories, Inc.). Nuclear DNA was
counterstained with 0.1 íg/mL 4,6-diamidino-2-phenylindole
(DAPI; Sigma) for 5 min at room temperature, washed with
PBS, and mounted in fluorescence medium. Negative
controls were performed by omitting the primary antibody
during staining. In all cases, no reactivity was observed when
the primary antibody was absent.
Toxicity of R-syn PF and DAPF Composed of A30P to
Neuronal Cell Cultures. After 24 h of incubation, neuron
cultures were treated with either PFA30P or DAPFA30P
generated by incubation of 50 íM A30P for 2 days at 37 °C
in the absence or presence of DA (50 íM), respectively, as
explained above. The toxic effects of these aggregates (at a
concentration of 10 íM) before and after HHP treatment (60
min under 2.7 kbar at 37 °C) were evaluated after 24 h of
incubation in neuronal cell cultures. Toxicity was evaluated
by counting the number of neurites per neuron, their length,
and also analyzing nuclear fragmentation. Neurons were
maintained in serum-free medium supplemented with B27.
Buffer A was used as a control.
Morphometry and Statistical Analysis. Neurons stained
with â-tubulin III antibody were photographed using a Nikon
microscope (Nikon Eclipse TE300). Photos were used to
analyze the number of neurites and the total neurite length
by using the Sigma Scan Pro Software (Jandel Scientific).
In each experiment (at least three independent experiments
were done), about 100 neurons per well, encompassing five
randomly chosen fields, were scored per condition. The data
were stored and analyzed graphically and statistically using
the Sigma Scanplot and Microsoft Excel version 7.0.
RESULTS
PF Are Lesser Packed than F: Effects of DA on Protofibril
Stability. To examine the effect of DA on the stability of
R-syn PF, we produced purified, 2-day-old PF in the absence
(called PF) or presence (called DAPF) of DA using wild-
type, A30P, or A53T proteins. Using electronic microscopy
(EM) and AFM, we were able to confirm the absence of
mature F in all of these preparations. By EM imaging (parts
A and B of Figure 1), the PFA30P and DAPFA30P solutions
presented small spherical aggregates with very few short F.
When these solutions were imaged by AFM (parts C and D
of Figure 1, respectively), the spherical aggregates were
shown to be heterogeneous in diameter (graphs below C and
D). The diameter of the PFA30P ranged in size from 90 to
240 nm (graph below C), while the diameter of the
DAPFA30P, although more homogeneous, ranged from 180
to 240 nm (graph below D). The images of the PF and DAPF
composed of the wild-type and A53T proteins were very
similar and are not presented.
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The morphology of the R-syn PF has already been
characterized by EM and AFM, where several different
morphologies were described, including spherical, annular,
pore-like, tube-like, and chain-like structures, and the extent
of each species observed is hightly dependent upon the
medium conditions (salts and pH) as well as on the time of
incubation (32). It has been shown that R-syn forms spherical
oligomers in the presence of DA (12 h of incubation at 37
°C), displaying a diameter of about 25 nm based on AFM
data (33). Here, we have used a longer incubation time (2
days), and this could explain the larger diameter observed
for the PF.
When all of these PF and DAPF were on hand, their
stabilities were then probed by subjecting them to increasing
pressures while monitoring the changes the LS to infer about
their integrity (Figure 2). Figure 2A shows that the LS signal
decreased by 90% for all three PF samples, compatible
with their dissociation into smaller species. Interestingly, in
the absence of DA, all three PF exhibited virtually identical
stability against HHP. The p1/2 values (pressure required to
achieve 50% dissociation) were in the range of 1000-1300
bar (Table 1). After pressure removal, the LS values remained
low (isolated symbols on the left), suggesting the irrever-
sibility of the process. This irreversible behavior is expected
because aggregation of R-syn depends upon sample agitation.
In the case of the mature F, as we reported before (23), there
were marked differences in stability among wild type and
variants, where Fwt presented the highest stability followed
by FA30P and FA53T (Table 1 and see also hollow symbols in
the right of Figure 4). When these data are taken together,
FIGURE 1: Analyzing the morphology of the PFA30P and DAPFA30P by EM and AFM. A30P (50 íM) was incubated under aggregating
conditions in the absence (PF) or presence of 50 íM DA (DAPF) and imaged by EM (PF ) A, and DAPF ) B) and AFM (PF ) C and
E, and DAPF ) D and F). These samples were subjected to 2170 bar/h at 37 °C and then analyzed by AFM (E and F). In AFM images,
the diameters of the aggregates were measured and are shown in the graphs below each image. Scale: EM ) 150 nm.
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they suggest that, at the protofibrillar stage, the contacts
within these aggregates are still weak and are dominated by
the main-chain contacts with little contribution from the side
chains of the amino acids. However, during maturation, the
conversion of PF into F seems to be accompanied by
structural changes within the fibril involving mainly side-
chain contacts, which contribute to fibril stability and
individuality.
In the presence of DA (Figure 2B), DAPF of R-syn (wild
type and variants) responded differently to HHP, with
DAPFwt being less stable than the DAPF composed of
variants (Table 1). Indeed, the latter dissociates by only 40-
50%, even at the highest pressure attainable in our experi-
mental setup (3000 bar). Again, after pressure removal, the
LS values remained low (isolated symbols on the left of B),
suggesting the irreversibility of the process. Thus, the
interaction between R-syn PF and DA confers a great stability
to the PF composed of the disease-associated R-syn (A30P
and A53T) with a modest change in PFwt stability (the p1/2
for the dissociation of PFwt and DAPFwt was almost the same,
1000 bar). In addition, the presence of DA seems to
anticipate PF individuality. These observations have impor-
tant physiological implications, given that in dopaminergic
neurons the presence of DA would stabilize the toxic PFA30P
and PFA30T species, which could explain the early onset of
the disease in the patients bearing these mutations.
Production of F in the Presence of DA (DAF) at Long
Incubation Times: Effects of DA on Fibril Stability. Under
appropriate conditions, R-syn fibrillization takes 6-7 days
(20, 26). In this time range, previous studies demonstrated
that DA inhibits R-syn fibrillization, resulting in the ac-
cumulation of oligomers and PF (15, 21, 32, 33). It was also
shown that an oxidized form of DA is responsible for this
activity (22, 33). Here, R-syn (wild type and variants) were
incubated in the presence of DA for an extended period of
time (18 days), resulting in the formation of amyloid F with
a typical morphology (upper images in Figure 3A), suggest-
ing that the PF formed in the presence of DA can evolve
into amyloid F. These F are referred to here as DAF.
Initially, we compared the binding of bis-ANS and Thio-T
to the wild-type, A53T, and A30P DAF with that displayed
by the respective fibril (Figure 3B), whose binding was taken
as 100%. As seen, the DAF composed of wild type or
variants displayed only 10% of the total Thio-T binding
capacity (hollow bars) of the fibril, while the bis-ANS
binding to DAF (filled bars) was 40% of that of the fibril,
except for A30P. It is possible that Thio-T and bis-ANS
compete with DA for the same binding sites within the
amyloid fibril, which could explain their diminished binding
to these F. When the proteins were incubated in the presence
of DA in an inert atmosphere, Thio-T binding increased to
40% (hollow bars with an upper N2 in B), consistent with
previously reported data demonstrating that an autoxidation
product(s) of DA is the active species in binding and
inhibiting R-syn fibrillization (21, 22).
To evaluate the effects of DA on fibril stability, we
subjected all DAF to HHP at 37 °C and the dissociation of
the F was monitored by LS (Figure 3C). As seen, DAFwt
(b) was the most unstable species, followed by DAFA53T (9),
while DAFA30P (2) was only partially dissociated under these
conditions. The p1/2 values for the dissociation of DAFwt and
DAFA53T were 1110 ( 110 and 1850 ( 190 bar, respectively
(Table 1). Interestingly, in the case of the F formed in the
absence of DA (23) (Table 1), the sequence of stability was
exactly the opposite, with the variant-composed F being the
most unstable species (FA53T < FA30P < Fwt). These results
suggest an important role of DA in modulating F as well as
PF (Figure 2B) stability.
Because DAFA30P was poorly dissociated by HHP at 37
°C, a pressure-titration curve was performed at 1 °C (4 in
Figure 3C). However, even at this low temperature, the
dissociation of DAFA30P was still incomplete, which suggests
that hydrophobic interactions are not the main contributing
factor in DAF stability.
Time-course experiments performed with all DAF con-
firmed the difference in stability among DAF (Figure 3D).
While the complete dissociation of DAFwt at 2170 bar
required less than 20 min (b), the dissociation of DAFA53T
occurred in 40 min (9). Again, DAFA30P did not dissociate
completely at this pressure value, and the LS decreased only
50%, even after 60 min under high pressure (2). Thus, the
FIGURE 2: Pressure-induced dissociation of PF and DAPF com-
posed of wild type or variants of R-syn. A total of 50 íM of each
soluble R-syn was incubated for 2 days under aggregating conditions
in the absence (PF) or presence of 50 íM DA (DAPF). Then, the
solutions were centrifuged to remove large aggregates, and the
supernatant was applied to the Superdex 200 (HR 10/30) column
to remove the remaining monomers. The peak corresponding to
the oligomerers was collected and immediately subjected to
increasing pressures at 37 °C, and the LS was recorded and divided
by the initial value (LS/LS0). A and B show, respectively, the
pressure-dissociation profiles of the PF and DAPF. Wild type (O
and b), A30P (4 and 2), and A53T (0 and 9). The isolated
symbols on the left represent the LS values observed after
decompression. Data are means of at least three independent
experiments.
Table 1: p1/2 Values for the Dissociation of All Aggregates of
R-syn Calculated from Figures 2 and 3a
wild type (bar) A30P (bar) A53T (bar)
PF 1350 ( 210 1000 ( 90 1200 ( 120
F (23) 2250 1650 950
DAPF 940 ( 130 NDb ND
DAF 1100 ( 110 ND 1850 ( 190
a Data are means ( standard error of the mean of at least three
independent experiments. b ND ) values not accessible because of
incomplete dissociation under those conditions.
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stability of DAF followed the same sequence as that of DAPF
(wild type < A53T < A30P) and was the opposite of that
observed for the F grown in the absence of DA (A53T <
A30P < wild type) (Table 1) (23).
This partial decrease in the LS observed with DAFA30P
might represent either the dissociation of a subpopulation
of pressure-sensitive DAFA30P or the homogeneous fragmen-
tation of all DAFA30P into oligomers still large in size. To
answer this question, EM images of the species formed after
decompression were obtained (lower images in Figure 3A).
As seen, after decompression (2170 bar/h), while the DAFwt
was drastically affected by the HHP treatment, in the
DAFA30P, there was a large population of intact F, suggesting
that only a minor fraction of DAFA30P may be sensitive to
HHP. In the case of DAFA53T, although several F were still
present after pressure treatment, there was a considerable
reduction in their concentration, because several fields of
the EM grid presented little or no F to be imaged.
Differences in PF and F Stability Might Contribute to
Dopaminergic Neuronal Loss in PD. In Figure 4, the
dissociation profiles of all PF (left panels) and F (right
panels) are grouped in pairs (grown in the absence (hollow
symbols) or presence (filled symbols) of DA) to give an idea
of what would be their expected behavior in nondopamin-
ergic versus dopaminergic neurons. With the wild-type
proteins (upper panels), the stabilities of the PF, DAPF, and
DAF were almost identical (p1/2  1000-1200 bar, Table
1), whereas the Fwt was considerably more stable. This means
that, in the dopaminergic region of the brain, the weak DAFwt
would easily brake into smaller toxic species, while in the
nondopaminergic regions, the nontoxic Fwt (p1/2 ) 2250 bar)
would prevail. This would tend to free the nondopaminergic
regions of the brain from the toxic effects of the smaller
FIGURE 3: R-syn forms F in the presence of DA after long incubation times, comparing the effects of HHP on DAF composed of the wild
type or variants. (A) EM images of the DAF formed after incubation of the wild type, A30P, and A53T (50 íM) under agitation at 37 °C
for 18 days in the presence of 50 íM DA before (upper images) or after (2170 bar/h; lower images) HHP treatment (bar ) 400 nm). (B)
Binding of Thio-T (hollow bars) and bis-ANS (filled bars) to DAF as compared to the control F, without DA (taken as 100%). The
influence of oxygen on the DA effect was evaluated by incubating the samples at 37 °C in an atmosphere enriched in nitrogen gas (bars
with N2). (C) Pressure-induced dissociation of wild type (b), A53T (9), and A30P (2) DAF (obtained in the presence of oxygen) as
followed by the LS decrease at 37 °C. The pressure was increased in steps and recorded after 15 min at each pressure value. (4) Dissociation
profile of DAFA30P at 1 °C. The isolated symbols on the left represent the LS values observed after decompression. (D) DAF were compressed
at 2170 bar at 37 °C, and the time course of dissociation was evaluated by the decrease in the LS. Data are means of at least three
independent experiments.
FIGURE 4: Comparing the stability of PF (left graphs) and F (right
graph) grown in the absence (O, 4, and 0) or presence (b, 2, and
9) of DA. A and B ) wild type, C and D ) A30P, and E and F
) A53T. Other conditions are the same as in Figures 2 and 3.
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aggregates, and indeed, the sporadic form of the disease
affects mostly the dopaminergic region (9).
In the case of the PF and F composed of the variants (parts
C and D of Figure 4 ) A30P, and parts E and F of Figure
4 ) A53T), DA alters considerably their stabilities. It is clear
that DA enhances stability at the level of the variant PF (filled
symbols on parts A, C, and E of Figure 4), which might
mean that, in dopaminergic neurons, when the toxic PF are
formed, they are already stable enough to persist and damage
these neurons. This effect is not observed with the wild-
type protein, where PF and DAPF have approximately equal
stabilities (Figure 4A and Table 1). Thus, although the DAF
composed of variants are more stable than their respective
F (parts D and F of Figure 4), the effects of DA in terms of
increasing stability are already perceptible at the level of PF.
Thus, we can postulate from these data that DA renders the
PF composed of the variants very stable, enabling them to
evade the cellular strategies that might dissolve these toxic
aggregates. This could explain their enhanced toxicity in the
dopaminergic regions of the brain. In the nondopaminergic
regions, PF composed of the variants are either very unstable
(as in the case of A30P) or as stable as the F (as in the case
of A53T).
The Toxicity of PFA30P and DAPFA30P to Neurons in
Culture Is Eliminated by HHP Treatment. To further
characterize the cytotoxic effect of the PF, DAPF, as well
as the species recovered from the HHP treatment, we selected
the A30P for this analysis. Initially, AFM imaging was
employed to better characterize the morphology of the
species present after HHP treatment (parts E and F of Figure
1 and graphs below them). As seen, after pressure treatment,
the PFA30P and DAPFA30P solutions presented only spherical
aggregates homogeneous in diameter (75-120 and 86-103
nm, respectively), being smaller than the aggregates present
before compression [diameter ranging from 130 to 182 nm
(PF) and 213 to 224 nm (DAPF)]. Those values are 95% of
the confidence interval of the geometrical mean, and it
suggests that HHP induces the fragmentation of these
spherical aggregates into smaller species.
To evaluate the toxic effects of PFA30P and DAPFA30P, these
aggregates were added to mesencephalic and cortical neurons
from 14-day-old embryonic (E14) mouse brains maintained
for 24 h in culture before morphological analysis of the
neurons. The length and number of neurites per neuron, as
well as the morphology of the nuclei [DNA staining with
4,6-diamidino-2-phenylindole (DAPI)] were evaluated (Fig-
ures 5 and 6). These experiments were performed with PF
(2-3 days old) because of the difficulty in keeping the
solutions sterile for longer times, when F appear.
Figure 5A shows images of healthy mesencephalic (a) and
cortical (a′) neurons in culture. They exhibited prolonged
processes and no sign of nuclear fragmentation (not shown
in detail). The addition of DA (50 íM) to these neurons did
not change their healthy appearance (d-d′). However, when
PFA30P (b and b′) or DAPFA30P (e and e′) were present, neurite
outgrowth and the number of neurites per neuron decreased
dramatically, as further quantified in Figure 6. In addition,
all of these toxic effects were accompanied by an evident
nuclear fragmentation with an apparent preservation of the
cytoplasm, suggesting an initial apoptotic process rather than
necrosis induced by PFA30P (not shown in magnification) and
DAPFA30P either in the mesencephalon (e in Figure 5B) or
in the cortex (e′ in Figure 5B).
Interestingly, the toxic effects of both PFA30P and DAPFA30P
were strongly reduced when the samples were previously
subjected to HHP treatment (2700 bar/h) (c and c′ and f and
f′ in Figure 5A). As seen, these neurons presented prolonged
processes and no sign of nuclear fragmentation (not shown
in magnification). When these data are taken together, they
suggest that, being able to break the PF and DAPF composed
of A30P into smaller aggregates (parts D and F in Figure
FIGURE 5: Evaluating the toxic effects of PFA30P and DAPFA30P to mesencephalic and cortical neurons in culture. (A) Images a-f are from
the mesencephalic, and images a′-f′ are from the cortical neurons from a 14-day-old embryonic (E14) mouse brain maintained for 24 h in
culture before subsequent treatment. Each cell culture was incubated for 24 h in the presence of a and a′, buffer (5 mM Tris and 100 mM
NaCl at pH 7.0); b and b′, PFA30P (grown in the absence of DA for 2 days); c and c′, PFA30P treated for 60 min at 2.7 kbar; d and d′, 50
íM DA solution; e and e′, DAPFA30P (grown for 2 days in the presence of 50 íM DA); and f and f′, DAPFA30P treated for 60 min at 2.7
kbar. Aggregate concentrations were 10 íM (monomer concentration). The neurons were stained with â-tubulin III antibody (green) and
DAPI (blue). (B) Magnification of the images shown in e (mesencephalic neurons treated with DAPFA30P) and e′ (cortical neurons treated
with DAPFA30P), where nuclear fragmentation as a sign of apoptosis is observed. Scale bar ) 40 ím (a-f′) and 5 ím (lower images).
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1), HHP treatment strongly reduces the associated toxicity
of these aggregates to neurons in culture.
The number of neurites per neuron as well as neurite length
were quantified as described in the Experimental Procedures
and are presented in Figure 6 and Table 2. In mesencephalic
cultures (left in Figure 6), the average neurite length of the
neurons treated with PF (bar b) or DAPF (bar e) was much
less (40 ím) than the average length in the control cultures
(80-100 ím, bar a). The addition of DA to these neurons
(bar d) increased neurite outgrowth (130-140 ím), suggest-
ing that they might be dopaminergic neurons.
In the case of the cortical neurons (right in Figure 6 and
Table 2), the average neurite length was 90-100 ím (bar
a′) and the presence of DA (bar d′) did not change this value
(90-100 ím). As observed with the mesencephalic neurons,
the presence of PFA30P (bar b′) or DAPFA30P (bar e′) decreased
the average length of the neurites to 70 or 70-80 ím,
respectively.
As mentioned before, the toxic effects of both PFA30P and
DAPFA30P were greatly reduced when the samples were
previously subjected to HHP treatment. As seen, the cultures
incubated in the presence of the “after pressure PF” (bars c
and c′ and Table 2) displayed the same neurite length (80-
100 ím in both neuron cultures) as the controls (bars a and
a′), while the “after pressure DAPF” (bar f and f′) had the
same neurite length as DA alone (d and d′) (80-100 ím in
both neuron cultures).
In regard to the number of neurons with 0, 1, or g2
neurites (lower graphs in Figure 6), it is noteworthy that, in
the control cultures, the majority of neurons have more than
two neurites per neuron, whether in mesencephalon (bar a)
or cortex (bar a′). DA alone did not affect the number of
neurites/neuron either in the mesencephalon (bar d) or cortex
(bar d′). The addition of DAPF to these cultures caused a
significant reduction in the number of neurites/neuron (bars
e and e′), where the majority of mesencephalic neurons
present one neurite per neuron, while the majority of cortical
neurons present one or more than two neurites. Interestingly,
the pattern of neurite distribution was recovered in the
cultures incubated in the presence of DAPFA30P previously
subjected to HHP treatment (compare a-f and a′-f′).
DISCUSSION
Amyloid F, regardless of the precursor protein, display a
common core structure that is characterized by the cross â
structure (24, 25). The structural properties, morphology, and
kinetics of amyloid-fibril formation are strongly influenced
by the amino acid sequence of the precursor protein as well
as the changes in the solution conditions under which they
were grown (34, 35). Studies from our laboratory and others
have shown that the primary sequence of the constituent
protein also plays an important role in modulating the
protein-protein contacts within the fibril, thus influencing
fibril stability (23, 36). For example, F composed of the wild-
type R-syn proved to be more stable to pressure denaturation
than the F composed of the disease-linked variants (A53T
and A30P). Also, the V30M variant of transthyretin (TTR)
was incompletely dissociated by HHP, while the wild-type
protein was completely dissociated in less than 5 min at 2500
bar (23).
In the case of â2m F, pressure treatment in the absence
of any added denaturant induced their conversion into a
species able to bind more Thio-T, suggesting that even the
amyloid F can assume different conformation, and HHP is
useful in revealing these new conformational states (37).
Recently, Bosharova and collaborators were able to show
that aggregates of the prion protein (PrP), when subjected
to heat treatment in the presence of Triton X-100, also
undergo rearrangements within the amyloid core, resulting
in the extension of the proteinase-K-resistant core. These data
argue in favor of the existence of different fibrilar states,
which might have important physiological implications in
the ethiology of their respective diseases (38).
Recently, Dirix and co-workers also reported that early
aggregates of a peptide from TTR were pressure-sensitive,
while mature aggregates derived from the same peptide were
pressure-resistant (36). These data are consistent with the
results presented here, where we show that, in going from
PF to F, there is a gain in stability (mainly observed with
wild type and A30P) (Table 1). Further, while all PF
exhibited an identical susceptibility to HHP regardless of
FIGURE 6: Evaluation of neuritogenesis in each cell culture treated
with the aggregates of A30P shown in Figure 1. A total of 100
neurons chosen randomly were analyzed, and the results are
expressed using the percentile plot, (*) p < 0.01. Upper panels
show the length of neurites from mesencephalic (left) and cortical
(right) neurons growing in the conditions described in the Experi-
mental Procedures. The boxes enclose the 25th and 75th percentiles
and are bisected by the median; whiskers indicate the 5th and 95th
percentiles. Note that the bars related to the pressure-treated samples
(c and f; c′ and f′) are similar to the controls (a and a′). Also note
that treatment with DA alone stimulated neurite growth in the
mesencephalon (bar d). An asterisk represents significant differences
(p < 0.01). Lower panels show the number of neurites per neuron
(0, 1, 2, or more) in mesencephalon (left) or in the cortex (right).
Again, the mesencephalic neurons treated with DAPFA30P (bare)
were more affected than the cortical neurons (e′). The distribution
of neurites per neuron in the cells incubated with pressure-treated
DAPFA30P (f and f′) was quite similar to the control.
Table 2: Average Neurite Length on Mesencephalic and Cortical
Neurons from the Brains of E14 Mice Treated with Different
Aggregates of A30P before and after HHP Treatment
condition
mesencephalic
neurons (ím)
cortical
neurons (ím)
control (buffer) 80-100 90-100
+PFA30P 40 70
+after pressure PFA30P 80-100 80-100
+DA (50 íM) 130-140 90-100
+DAPFA30P 40 70-80
+after pressure DAPFA30P 80-100 80-100
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the primary sequence of the constituent protein, the F respond
differently, with the Fwt being the most stable among them.
These results suggest that during fibrillogenesis several
structural changes take place within the amyloid structure,
as summarized below:
Differences in stability among all of these species are
probably related to the presence of void volume and packing
defects. In general, the species that are more susceptible to
HHP are the ones with internal void volumes (water-excluded
cavities), dry interfaces, and the presence of hydrophobic
and electrostatic interactions (39-41).
Previous studies performed by Lansbury and others have
shown that, with short incubation times, DA interacts with
R-syn and inhibits the conversion of PF into F (21). However,
as shown here, upon longer incubations, mature amyloid F
of R-syn were observed to form in the presence of equimolar
concentrations of DA, an observation that has not been
reported before. It is possible that, with aging, a fraction of
the R-syn-bound DA molecules detach from the PF, allowing
the latter to evolve into F. However, because the F grown
in the absence and presence of DA responded differently to
HHP treatment, we postulate that at least some DA molecules
remain bound to the protein in the F and modulate their
stability, possibly through modulating structural changes
involved in protein-protein interactions within the F.
The data presented here examine for the first time the idea
that there is an effect of DA on the thermodynamic stability
of the PF and F of R-syn, with important correlations with
PD etiology. Our data show clearly that DA exerts a
considerable effect in modulating PF and F stability, and
this modulation depends upon the protein that constitutes
the aggregates (Figure 4). Variant PF, when grown in the
presence of DA, exhibited a notable gain in stability (Figures
2 and 4), and this could be associated with their early onset
in PD patients. Although other regions of the brain are also
affected in patients bearing these mutations (8), the dopam-
inergic region presents an increased susceptibility that has
been attributed to the presence of the catecholamines. Thus,
here, we propose an additional role of DA that is its
differential modulation of the stability of the aggregate
species of R-syn. This stabilizing effect is not observed in
the case of wild-type R-syn, where PFwt and DAPFwt are
equally stable under pressure (Figure 4). However, DAFwt
is much more unstable than Fwt. It is tempting to suggest
that, in the dopaminergic neurons, the presence of DA would
render the F composed of wild-type R-syn very labile,
enhancing the possibility of their breaking into smaller, toxic
species and causing damage specifically to this region of
the brain. In nondopaminergic neurons, because of the
absence of DA, Fwt as a stable entity would remain as an
inert material, sparing this region from damage. Considering
that the vast majority of PD cases are sporadic and involve
the wild-type protein, these observations have important
physiological implications.
It is noteworthy that R-syn aggregation and toxicity are
also implicated in the pathogenesis of several neurodegen-
erative diseases, including Alzheimer’s disease, multiple-
system atrophy, dementia with LB, Down syndrome, and
neurodegeneration with brain iron accumulation, collectively
referred to as synucleinopathies (42, 43). The presence of
R-syn aggregates within LB and Lewy neurites in brain
regions other than the substantia nigra and within different
population of neurons (dopaminergic and nondopaminergic)
suggests that toxicity of the R-syn aggregates does not depend
exclusively upon the presence of DA. However, it is likely
that the stability of R-syn aggregates within these inclusions
is also modulated by the interactions between R-syn and other
macromolecule, as well as by the post-translational modifica-
tions that take place with R-syn.
To understand the role of DA in modulating the toxic
properties of R-syn aggregates, we evaluated the toxicity of
PFA30P and DAPFA30P before and after HHP treatment using
mesencephalic and cortical neurons in cultures (Figures 5
and 6). Our data show that the mesencephalic neurons seem
to be more sensitive than cortical neurons to the presence of
either aggregate, although the percentage of dopaminergic
neurons in these cultures is in the range of 17-21% (44).
Strikingly, when the neuronal cultures are incubated in the
presence of samples treated under pressure at 2700 bar for
1 h, these neurons present a healthy aspect, suggesting that
the species rescued from high pressure loses its toxicity.
AFM images (parts C-F of Figure 1) revealed that, after
pressure treatment, the average diameter of the spheri-
cal aggregates present before compression decreased
significantly (Dunn’s multiple comparison test, p < 0.01),
and this may explain the decrease in toxicity. Besides, nuclear
fragmentation was observed in all cultures treated with PFA30P
and DAPFA30P (Figure 5), and again, these effects are
reversed by HHP treatment. It has been reported that the
overexpression of human R-syn in rat neuronal cells results
in a significant reduction of neurite expansion (45). However,
very few data in the literature describe the toxic effects of
adding aggregates of R-syn to neurons in culture as we show
here. This approach has an important implication because
the presence of R-syn in plasma has recently been described
(46). Besides, because the addition of aggregates is much
easier than R-syn transfection, it could be used as a first
approach in drug screening.
The observation that the cytotoxicity of the DAPFA30P is
almost completely abolished after pressure treatment despite
the fact that these PF are only partially dissociated by HHP
(Figure 2) suggests that R-syn toxicity is mediated by specific
protofibrillar structures that are susceptible to pressure
denaturation. Recently, in an elegant study, Silveira and co-
workers (47) were able to isolate a subpopulation responsible
for infectivity and by the converting activity of the PrP(res)
in transmissible spongiform encephalopathy. This subpopu-
lation contains aggregates of a size compatible with only
14-28 molecules of the PrP.
The mechanism by which these aggregates of R-syn exert
their toxic effects remains unclear now. An important
question that arises from this observation is the precise site
of action of these aggregates on the outside of the cells.
Further studies are necessary to address this issue.
monomer f PF f F
unpacked not well packed well packed
no cavities cavities fewer cavities
unstructured main-chain contacts side-chain contacts
highly hydrated less hydrated less hydrated
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